MRCCC Siloam Hospitals has taken a bold step in the fight against breast cancer with the installation of Indonesia’s first Mammomat B.Brilliant from Siemens Healthineers. Breast cancer remains the most common cancer among women in Indonesia, accounting for around 19% of all cancer cases, with more than 70,000 new diagnoses each year1 (GLOBOCAN). Yet survival rates can drastically improve if the disease is caught early—making timely and accurate screening crucial.
The Mammomat B.Brilliant is more than just a mammography system; it’s a leap forward in imaging precision, patient comfort, and clinical efficiency. With cutting-edge imaging software, ultra-sharp resolution at a low radiation dose, and faster, more comfortable exams, it empowers radiologists to detect even the smallest irregularities earlier and more confidently. For women, it transforms what can be an anxious experience into one that is quicker, gentler, and reassuring—because every moment saved can be a life saved.
For MRCCC, this installation cements its role as a Center of Excellence for Cancer Care, offering patients access to diagnostic capabilities on par with world-leading cancer institutions. “This milestone is more than just a technological upgrade—it’s a powerful statement of our commitment to protecting women’s health,” said dr. Edy Gunawan, MARS, CEO of MRCCC Siloam Hospitals. “We want to inspire more women to take charge of their health, come forward for screenings, and give themselves the best chance at beating breast cancer”
Alfred Fahringer, President Director of Siemens Healthineers Indonesia, added: “We are proud to partner with MRCCC in bringing the Mammomat B.Brilliant to Indonesia for the very first time. This system embodies our mission to pioneer breakthroughs in healthcare—for everyone, everywhere. Together, we’re not just delivering a machine, we’re delivering hope, earlier answers, and the chance for more women to live longer, healthier lives.”
About Siemens Healthineers
Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2025, which ended on September 30, 2025, Siemens Healthineers had approximately 74,000 employees worldwide and generated revenue of around €23.4 billion. Further information is available at siemens-healthineers.com.
Contact for media enquiries, please get in touch with:
Siemens Healthineers Indonesia
Evan Akira Zuraida
Head of Communications, Indonesia
Phone: +62 811 965 09947
E-mail: evan.akira@siemens-healthineers.com